Effect of individual reminiscence for older adults with mild to moderate dementia in nursing homes

SolCos based-model individual reminiscence for older adults with mild to moderate dementia in ?nursing homes: A randomized controlled intervention study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN74355073

Enrollment

200

Registered

2015-12-03

Start date

2014-12-15

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Mental and Behavioural Disorders Dementia

Interventions

Initial study: Study participants are randomly allocated to one of two groups. Control group: Participants continue to receive normal care only. Inter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 60 years or over 2. Diagnosed with major neurocognitive disorder according to DSM-V criteria with a Mini-Mental State Examination 10 3. Considered by their physician or nurses to have mental capacity and sufficient verbal communication abilities to engage with the study 4. Living in a study nursing home

Exclusion criteria

Exclusion criteria: 1. Mini-Mental State Examination (MMSE) > 24 and < 10 2. Verbal communication issues which prevent engagement with the study

Design outcomes

Primary

Measure	Time frame
Initial study: 1. Cognition is assessed using the Mini-Mental State Examination (MMSE) screening tool at baseline and 8 weeks 2. Frontal lobe function is assessed using the Frontal Assessment Battery (FAB) at baseline and 8 weeks 3. Behavioural disturbances are assessed using the Neuropsychiatric Inventory (NPI) at baseline and 8 weeks 4. Depression symptoms are assessed using the Cornell Scale for Depression in Dementia (CSDD) at baseline and 8 weeks Follow up study: 1. Cognition assessed using the Mini-Mental Examination (MMSE) screening tool at baseline and 8 weeks 2. Behavioural disturbances are assessed using the Neuropsychiatric Inventory (NPI) at baseline and 8 weeks 3. Depression symptoms are assessed using the Cornell Scale for Depression in Dementia (CSDD) at baseline and 8 weeks 4. Quality of life assessed with the dedicated scale QUALIDEM at baseline and 8 weeks	—

Measure

Time frame

Initial study: 1. Cognition is assessed using the Mini-Mental State Examination (MMSE) screening tool at baseline and 8 weeks 2. Frontal lobe function is assessed using the Frontal Assessment Battery (FAB) at baseline and 8 weeks 3. Behavioural disturbances are assessed using the Neuropsychiatric Inventory (NPI) at baseline and 8 weeks 4. Depression symptoms are assessed using the Cornell Scale for Depression in Dementia (CSDD) at baseline and 8 weeks Follow up study: 1. Cognition assessed using the Mini-Mental Examination (MMSE) screening tool at baseline and 8 weeks 2. Behavioural disturbances are assessed using the Neuropsychiatric Inventory (NPI) at baseline and 8 weeks 3. Depression symptoms are assessed using the Cornell Scale for Depression in Dementia (CSDD) at baseline and 8 weeks 4. Quality of life assessed with the dedicated scale QUALIDEM at baseline and 8 weeks

—

Secondary

Measure	Time frame
Secondary outcomes for both the initial study and follow up study completed by facilitators in the intervention group: 1. Residents’ attention and participation during the session measured using a 10-item survey after each session 2. Session conditions and facilitators’ experiences measured using an 11-item survey after each session	—

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 1, 2026